The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia

Journal of Psychiatric Research

Volumn 46, Issue 6, 2012, Pages 733-737

  Hui, Li ^a   Zhang, Xuan ^a   Huang, Xu Feng ^b,c   Han, Mei ^b,c   Fernandez, Francesca ^b,c   Yu, Yaqin ^a   Sun, ShiLong ^a   Li, Wenjun ^a   Chen, Da Chun ^d   Xiu, Mei Hong ^d   Kosten, Thomas R ^d,e   Zhang, Xiang Yang ^d,e  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d PEKING UNIVERSITY   (China)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Case control association; Chronic schizophrenia; Dopamine beta hydroxylase polymorphism; First episode schizophrenia

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SEQUENCE DELETION; YOUNG ADULT;

EID: 84862791804     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.02.016     Document Type: Article

References (35)

1. Arnsten A.F. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Progress in Brain Research 2000, 126:183-192.
2. Chen Y., Wen G., Rao F., Zhang K., Wang L., Rodriguez-Flores J.L., et al. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. Journal of Hypertension 2010, 28(1):76-86.
3. Cimarusti D.L., Saito K., Vaughn J.E., Barber R., Roberts E., Thomas P.E. Immunocytochemical localization of dopamine-beta-hydroxylase in rat locus coeruleus and hypothalamus. Brain Research 1979, 162:55-67.
4. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Human Genetics 1998, 102:533-540.
5. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., et al. A haplotype at the DBH locus, associated with low plasma dopamine betahydroxylase activity, also associates with cocaine-induced paranoia. Molecular Psychiatry 2000, 5:56-63.
6. Cubells J.F., Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology 2004, 174:463-476.
7. Cubells J.F., Sun X., Li W., Bonsall R.W., McGrath J.A., Avramopoulos D., et al. Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia. Human Genetics 2011, 130:635-643.
8. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 1991, 148:1474-1486.
9. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 2008, 66:87-98.
10. Dunnette J., Weinshilboum R. Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. American Journal of Human Genetics 1976, 28:155-166.
11. Gauderman W.J. Sample size requirements for matched case-control studies of gene environment interaction. Statistics in Medicine 2002, 21:35-50.
12. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 2002, 111:815-835.
13. Hartmann E., Keller-Teschke M. The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects. Biological Psychiatry 1979, 14:455-462.
14. Kaufmann C.A., Suarez B., Malaspina D., Pepple J., Svrakic D., Markel P.D., et al. NIMH genetics initiative millenium schizophrenia consortium: linkage analysis of African-American pedigrees. American Journal of Medical Genetics 1998, 81:282-289.
15. Kemper C.M., O'Connor D.T., Westlund K.N. Immunocytochemical localization of dopaminebeta-hydroxylase in neurons of the human brain stem. Neuroscience 1987, 23:981-989.
16. Klimek V., Rajkowska G., Luker S.N., Dilley G., Meltzer H.Y., Overholser J.C., et al. Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology 1999, 21:69-81.
17. Lang U.E., Puls I., Muller D.J., Strutz-Seebohm N., Gallinat J. Molecular mechanisms of schizophrenia. Cellular Physiology & Biochemistry 2007, 20:687-702.
18. Markianos E.S., Nystrom I., Reichel H., Matussek N. Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol. Psychopharmacology 1976, 50:259-267.
19. Meltzer H.Y., Cho H.W., Carroll B.J., Russo P. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients. Archives of General Psychiatry 1976, 33:585-591.
20. Meszaros K., Lenzinger E., Fureder T., Hornik K., Willinger U., Stompe T., et al. Schizophrenia and the dopamine-beta-hydroxylase gene: results of a linkage and association study. Psychiatric Genetics 1996, 6:17-22.
21. Moncrieff J. A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard Review of Psychiatry 2009, 17(3):214-225.
22. Park J.K., Kim J.W., Lee H.J., Chung J.H., Ha E.Y., Oh D.J., et al. Dopamine beta-hydroxylase gene polymorphisms and psychotic symptoms in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:944-945.
23. Perry S.E., Summar M.L., Phillips J.A., Robertson D. Linkage analysis of the human dopamine beta-hydroxylase gene. Genomics 1991, 10:493-495.
24. Riley B.P., Tahir E., Rajagopalan S., Mogudi-Carter M., Faure S., Weissenbach J., et al. A linkage study of the N-methyl-D-aspartate receptor subunit gene loci and schizophrenia in southern African Bantu-speaking families. Psychiatric Genetics 1997, 7:57-74.
25. Sack R.L., Goodwin F.K. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid. Archives of General Psychiatry 1974, 31:649-654.
26. Sapru M.K., Rao B.S., Channabasavanna S.M. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression. Acta Psychiatrica Scandinavica 1989, 80:474-478.
27. Sternberg D.E., van Kammen D.P., Lerner P., Ballenger J.C., Marder S.R., Post R.M., et al. CSF dopamine beta-hydroxylase in schizophrenia. Archives of General Psychiatry 1983, 40:743-747.
28. Tang Y.L., Epstein M.P., Anderson G.M., Zabetian C.P., Cubells J.F. Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans. European Journal of Human Genetics 2007, 15:878-883.
29. Togsverd M., Werge T.M., Tanko L.B., Bagger Y.Z., Qin G.G., Hansen T., et al. Cognitive performance in elderly women: significance of the 19bp insertion/deletion polymorphism in the 5' flank of the dopamine beta-hydroxylase gene, educational level, body fat measures, serum triglyceride, alcohol consumption and age. International Journal of Geriatric Psychiatry 2007, 22:883-889.
30. Togsverd M., Werge T.M., Tankó L.B., Bagger Y.Z., Hansen T., Qin G., et al. Association of a dopamine beta-hydroxylase gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction. Journal of Affective Disorders 2008, 106(1-2):169-172.
31. van Kammen D.P., Kelley M.E., Gilbertson M.W., Gurklis J., O'Connor D.T. CSF dopamine betahydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures. American Journal of Psychiatry 1994, 151:372-378.
32. Williams H.J., Bray N., Murphy K.C., Cardno A.G., Jones L.A., Owen M.J. No evidence for allelic association between schizophrenia and a functional variant of the human dopamine beta-hydroxylase gene (DBH). American Journal of Medical Genetics 1999, 88:557-559.
33. Wilson A.F., Elston R.C., Siervogel R.M., Tran L.D. Linkage of a gene regulating dopamine-betahydroxylase activity and the ABO blood group locus. American Journal of Human Genetics 1988, 42:160-166.
34. Yamamoto K., Cubells J.F., Gelernter J., Benkelfat C., Lalonde P., Bloom D., et al. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003, 117B:33-38.
35. Zabetian C.P., Anderson G.M., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. American Journal of Human Genetics 2001, 68:515-522.